skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Isothiocyanate-Functionalized Bifunctional Chelates and fac -[M I (CO) 3 ] + (M = Re, 99m Tc) Complexes for Targeting uPAR in Prostate Cancer

Journal Article · · Bioconjugate Chemistry
 [1];  [2];  [3];  [3];  [1];  [1];  [4];  [3];  [1]
  1. Washington State Univ., Pullman, WA (United States)
  2. Stanford Univ., CA (United States); Fourth Military Medical Univ., Xi'an (China)
  3. Stanford Univ., CA (United States)
  4. National Soil Tilth Lab., Ames, IA (United States)

Developing new strategies to rapidly incorporate the fac-[MI(CO)3]+. (M = Re, 99mTc) core into biological targeting vectors in radiopharmaceuticals continues to expand as molecules become more complex and as efforts to minimize nonspecific binding increase. This work examines a novel isothiocyanate-functionalized bifunctional chelate based on 2,2'-dipicolylamine (DPA) specifically designed for complexing the fac-[MI(CO)3]+. core. Two strategies (postlabeling and prelabeling) were explored using the isothiocyanate-functionalized DPA to determine the effectiveness of assembly on the overall yield and purity of the complex with amine containing biomolecules. A model amino acid (lysine) examined (1) amine conjugation of isothiocyanate-functionalized DPA followed by complexation with fac-[MI(CO)3]+. (postlabeling) and (2) complexation of fac-[MI(CO)3]+. with isothiocyanate-functionalized DPA followed by amine conjugation (prelabeling). Conducted with stable Re and radioactive 99mTc analogs, both strategies formed the product in good to excellent yields under macroscopic and radiotracer concentrations. A synthetic peptide (AE105) which targets an emerging biomarker in CaP prognosis, urokinase-type plasminogen activator receptor (uPAR), was also explored using the isothiocyanate-functionalized DPA strategy. In vitro PC-3 (uPAR+) cell uptake assays with the 99mTc-labeled peptide (8a) showed 4.2 ± 0.5% uptake at 4 h. In a murine model bearing PC-3 tumor xenografts, in vivo biodistribution of 8a led to favorable tumor uptake (3.7 ± 0.7% ID/g) at 4 h p.i. with relatively low accumulation (<2% ID/g) in normal organs not associated with normal peptide excretion. These results illustrate the promise of the isothiocyanate-functionalized approach for labeling amine containing biological targeting vectors with fac-[MI(CO)3]+.

Research Organization:
Stanford Univ., CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
SC0008397
OSTI ID:
1467664
Journal Information:
Bioconjugate Chemistry, Vol. 27, Issue 1; ISSN 1043-1802
Publisher:
American Chemical SocietyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 8 works
Citation information provided by
Web of Science

References (79)

Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex journal September 1999
A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules:  Synthesis of [ 99m Tc(OH 2 ) 3 (CO) 3 ] + from [ 99m TcO 4 ] - in Aqueous Solution and Its Reaction with a Bifunctional Ligand journal August 1998
Mono-, bi-, or tridentate ligands? The labeling of peptides with99mTc-carbonyls journal January 2004
Clickable, Hydrophilic Ligand for fac- [M I (CO) 3 ] + (M = Re/ 99m Tc) Applied in an S -Functionalized α-MSH Peptide journal February 2014
“Click” labeling strategy for M(CO)3 (M = Re, 99mTc) prostate cancer targeted Flutamide agents journal January 2010
Click Chemistry: Diverse Chemical Function from a Few Good Reactions journal June 2001
Click Chemistry beyond Metal-Catalyzed Cycloaddition journal June 2009
Cu-free click cycloaddition reactions in chemical biology journal January 2010
Click-Chemistry Reactions in Radiopharmaceutical Chemistry: Fast & Easy Introduction of Radiolabels into Biomolecules for In Vivo Imaging journal April 2010
Bioconjugation with Strained Alkenes and Alkynes journal September 2011
From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions journal September 2011
The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals journal April 2013
Cu-Free 1,3-Dipolar Cycloaddition Click Reactions To Form Isoxazole Linkers in Chelating Ligands for fac -[M I (CO) 3 ] + Centers (M = Re, 99m Tc) journal December 2013
Site directed maleimide bifunctional chelators for the M(CO)3+ core (M =99mTc, Re) journal January 2005
Photo-initiated Thiol-ene Click Reactions as a Potential Strategy for Incorporation of [M I (CO) 3 ] + (M = Re, 99m Tc) Complexes journal February 2013
The hydrazide/hydrazone click reaction as a biomolecule labeling strategy for M(CO)3 (M = Re, 99mTc) radiopharmaceuticals journal January 2011
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. journal June 1988
Technetium-labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC (CPITC=carboxyphenylisothiocyanate) labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2 journal November 1991
Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC [phenyl isothiocyanate]. journal May 1991
Labeling of proteins by organometallic complexes of rhenium(I). Synthesis and biological activity of the conjugates journal November 1993
Labeling Cyclic Glycoprotein IIb/IIIa Receptor Antagonists with 99m Tc by the Preformed Chelate Approach:  Effects of Chelators on Properties of [ 99m Tc]Chelator−Peptide Conjugates journal January 1996
188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides journal October 1998
Side-chain selective and covalent labelling of proteins by organometallic complexes of heavy transition metals. Possible application in radio-crystallography of proteins journal November 1998
Functionalized Rhenium(V) Organoimido Complexes as Potential Radiopharmaceuticals. 2. Synthesis, Structural Characterization, and Reactivity of N -Succinimidyl Ester Derivatives with Amines journal March 2000
Preparation and preliminary evaluation of 99mTc-EC-For-MLFK journal July 2002
2,3,5,6-Tetrafluorophenyl N -( S -Benzoylthioacetyl)glycylglycyl- p -aminobenzoate, a Heterobifunctional 99m Tc Ligand for Precomplexed Antibody Labeling journal November 2003
Radiochemical Investigations of 99m Tc−N 3 S-X-BBN[7−14]NH 2 :  An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties journal January 2003
Production of Multimeric Prostate-Specific Membrane Antigen Small-Molecule Radiotracers Using a Solid-Phase 99mTc Preloading Strategy journal August 2007
Quantitation of CXCR4 Expression in Myocardial Infarction Using 99m Tc-Labeled SDF-1α journal May 2008
Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs journal May 1997
Protein and Peptide Labeling with (Cyclopentadienyl)tricarbonyl Rhenium and Technetium journal November 1998
Synthesis and biological evaluation of tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide journal January 1999
Therapeutic Radiopharmaceuticals journal September 1999
Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes journal June 2006
Preparation and Properties of 99m Tc(CO) 3 + -Labeled N , N -Bis(2-pyridylmethyl)-4-aminobutyric Acid journal October 2004
Design and synthesis of site directed maleimide bifunctional chelators for technetium and rhenium journal January 2005
Comprehensive Radiolabeling, Stability, and Tissue Distribution Studies of Technetium-99m Single Amino Acid Chelates (SAAC) journal August 2009
Imaging of Urokinase-Type Plasminogen Activator Receptor Expression Using a 64Cu-Labeled Linear Peptide Antagonist by microPET journal August 2008
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers journal May 2012
Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes journal November 2011
Quantitative PET of Human Urokinase-Type Plasminogen Activator Receptor with 64Cu-DOTA-AE105: Implications for Visualizing Cancer Invasion journal January 2012
First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts journal July 2013
Tumor markers in prostate cancer I: Blood-based markers journal May 2011
The Many Spaces of uPAR: Delivery of Theranostic Agents and Nanobins to Multiple Tumor Compartments through a Single Target journal January 2013
Other biomarkers for detecting prostate cancer journal January 2010
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style journal March 2014
Urokinase receptor: a molecular organizer in cellular communication journal October 2000
Protease Crosstalk with Integrins: the Urokinase Receptor Paradigm journal January 2001
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor journal July 2003
Regulation of cell signalling by uPAR journal January 2010
The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis journal January 2001
Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme journal January 2012
Role of Urokinase Receptor in Tumor Progression and Development journal January 2013
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy journal January 2003
Synthesis and Characterization of an 111 In-Labeled Peptide for the in Vivo Localization of Human Cancers Expressing the Urokinase-Type Plasminogen Activator Receptor (uPAR) journal April 2009
Strained Cyclooctyne as a Molecular Platform for Construction of Multimodal Imaging Probes journal March 2015
Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging journal December 2008
Targeting uPA/uPAR in prostate cancer journal October 2007
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy for disseminated ovarian cancer journal September 2007
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts journal October 2012
uPAR Targeted Radionuclide Therapy with 177 Lu-DOTA-AE105 Inhibits Dissemination of Metastatic Prostate Cancer journal July 2014
Association of the Circulating Levels of the Urokinase System of Plasminogen Activation With the Presence of Prostate Cancer and Invasion, Progression, and Metastasis journal February 2007
Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer. journal March 1999
Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer journal May 1999
Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum journal May 2006
Association of Tissue mRNA and Serum Antigen Levels of Members of the Urokinase-Type Plasminogen Activator System with Clinical and Prognostic Parameters in Prostate Cancer journal January 2014
A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate journal May 2008
A New Strategy for the Preparation of Peptide-Targeted Radiopharmaceuticals Based on an Fmoc-Lysine-Derived Single Amino Acid Chelate (SAAC). Automated Solid-Phase Synthesis, NMR Characterization, and in Vitro Screening of fMLF(SAAC)G and fMLF[(SAAC−Re(CO) 3 ) + ]G journal January 2004
Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin journal January 1990
Synthesis of 4-([18F]Fluoromethyl)phenyl Isothiocyanate and its Use in Labelling Oligonucleotides. journal January 1997
[ 18 F]SiFA-isothiocyanate: A New Highly Effective Radioactive Labeling Agent for Lysine-Containing Proteins journal May 2009
Improved PET Imaging of uPAR Expression Using new 64 Cu-labeled Cross-Bridged Peptide Ligands: Comparative in vitro and in vivo Studies journal January 2013
Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor journal November 2009
Peptide-Derived Antagonists of the Urokinase Receptor. Affinity Maturation by Combinatorial Chemistry, Identification of Functional Epitopes, and Inhibitory Effect on Cancer Cell Intravasation journal October 2001
Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPY journal February 2010
Re(CO) 3 Complexes Synthesized via an Improved Preparation of Aqueous f ac -[Re(CO) 3 (H 2 O) 3 ] + as an Aid in Assessing 99m Tc Imaging Agents. Structural Characterization and Solution Behavior of Complexes with Thioether-Bearing Amino Acids as Tridentate Ligands journal July 2005
Fluorescent and Affinity-Based Tools To Detect Cysteine Sulfenic Acid Formation in Proteins journal November 2007
Novel, Cysteine-Modified Chelation Strategy for the Incorporation of [M I (CO) 3 ] + (M = Re, 99m Tc) in an α-MSH Peptide journal October 2012
A Comparative Study of Radiolabeled Bombesin Analogs for the PET Imaging of Prostate Cancer journal November 2013

Cited By (1)

Towards dual SPECT/optical bioimaging with a mitochondrial targeting, 99m Tc( i ) radiolabelled 1,8-naphthalimide conjugate journal January 2020